spacer
spacer

PDBsum entry 1npm

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Serine proteinase PDB id
1npm

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
223 a.a. *
Ligands
NAG ×2
Waters ×194
* Residue conservation analysis
PDB id:
1npm
Name: Serine proteinase
Title: Neuropsin, a serine protease expressed in the limbic system of mouse brain
Structure: Neuropsin. Chain: a, b. Engineered: yes
Source: Mus musculus. House mouse. Organism_taxid: 10090. Cell_line: high5. Organ: hippocampus. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: high5.
Resolution:
2.10Å     R-factor:   0.186     R-free:   0.227
Authors: T.Kishi,M.Kato,T.Shimizu,K.Kato,K.Matsumoto,S.Yoshida,S.Shiosaka, T.Hakoshima
Key ref:
T.Kishi et al. (1999). Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis. J Biol Chem, 274, 4220-4224. PubMed id: 9933620 DOI: 10.1074/jbc.274.7.4220
Date:
07-Jan-98     Release date:   23-Mar-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q61955  (KLK8_MOUSE) -  Kallikrein-8 from Mus musculus
Seq:
Struc:
260 a.a.
223 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.4.21.118  - kallikrein 8.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1074/jbc.274.7.4220 J Biol Chem 274:4220-4224 (1999)
PubMed id: 9933620  
 
 
Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis.
T.Kishi, M.Kato, T.Shimizu, K.Kato, K.Matsumoto, S.Yoshida, S.Shiosaka, T.Hakoshima.
 
  ABSTRACT  
 
Neuropsin is a novel serine protease, the expression of which is highly localized in the limbic areas of the mouse brain and which is suggested to be involved in kindling epileptogenesis and hippocampal plasticity. The 2.1-A resolution crystal structure of neuropsin provides the first three-dimensional view of one of the serine proteases highly expressed in the nervous system, and reveals a serine protease fold that exhibits chimeric features between trypsin and nerve growth factor-gamma (NGFgamma), a member of the kallikrein family. Neuropsin possesses an N-glycosylated "kallikrein loop" but forms six disulfide bonds corresponding to those of trypsin. The ordered kallikrein loop projects proline toward the active site to restrict smaller residues or proline at the P2 position of substrates. Loop F, which participates in forming the S3/S4 sites, is similar to trypsin rather than NGFgamma. The unique conformations of loops G and H form an S1 pocket specific for both arginine and lysine. These characteristic loop structures forming the substrate-binding site suggest the novel substrate specificity of neuropsin and give a clue to the design of its specific inhibitors.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Overall structure of neuropsin. a, ribbon representation of neuropsin. Seven-stranded -sheets (the top and bottom halves) are sandwiched with the catalytic triad at the cleft of the -sandwich. The surface loops (A-H) forming the substrate-binding site are colored with labels. Six disulfide bonds are shown by bridges in white, and the disulfide bond (SS3), which is conserved in trypsin but not in kallikrein, was labeled. Loop D is the kallikrein loop that has an N-glycosylated Asn95 with one visible GlcNAc residue. The side chains of the catalytic triad, Asp189 at the S1-specific pocket, Lys175 at the S3/4 site, Glu149 and Asp218 at the rim of the S1 pocket, and Leu40 and Ile^41 at the S1' site, are also shown with stick representations with one-letter amino acid labels. b, molecular surfaces of neuropsin viewed from nearly the same direction of panel a. Surface electrostatic potentials calculated and rendered using GRASP (negative potentials are in red and positive in blue). The S1-S4 and S1' sites and characteristic surface residues are labeled.
Figure 4.
Fig. 4. Comparison of the surface loops forming the S2 site between neuropsin (colored) and -thrombin (gray). The C[ ]-carbon atom tracings of loops of neuropsin, colored as in Fig. 1a, are superimposed on -thrombin complexed with D-Phe-Pro-Arg-chloromethylketone (green). The van der Waals surfaces of the inhibitor peptide and P95D are shown with dot-surface representations. Labels are as in Fig. 3.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (1999, 274, 4220-4224) copyright 1999.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20615447 P.Goettig, V.Magdolen, and H.Brandstetter (2010).
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
  Biochimie, 92, 1546-1567.  
18844454 J.A.Clements (2008).
Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?
  Biol Chem, 389, 1447-1454.  
17976015 C.A.Borgoño, J.A.Gavigan, J.Alves, B.Bowles, J.L.Harris, G.Sotiropoulou, and E.P.Diamandis (2007).
Defining the extended substrate specificity of kallikrein 1-related peptidases.
  Biol Chem, 388, 1215-1225.  
17417874 S.I.Blaber, H.Yoon, I.A.Scarisbrick, M.A.Juliano, and M.Blaber (2007).
The autolytic regulation of human kallikrein-related peptidase 6.
  Biochemistry, 46, 5209-5217.  
17487847 Z.X.Lu, J.Peng, and B.Su (2007).
A human-specific mutation leads to the origin of a novel splice form of neuropsin (KLK8), a gene involved in learning and memory.
  Hum Mutat, 28, 978-984.  
16800733 T.Kishi, S.M.Cloutier, C.Kündig, D.Deperthes, and E.P.Diamandis (2006).
Activation and enzymatic characterization of recombinant human kallikrein 8.
  Biol Chem, 387, 723-731.  
15651049 G.Laxmikanthan, S.I.Blaber, M.J.Bernett, I.A.Scarisbrick, M.A.Juliano, and M.Blaber (2005).
1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
  Proteins, 58, 802-814.
PDB code: 1spj
15578663 O.Guvench, D.J.Price, and C.L.Brooks (2005).
Receptor rigidity and ligand mobility in trypsin-ligand complexes.
  Proteins, 58, 407-417.  
15610180 A.Bahi, F.Boyer, C.Gumy, T.Kafri, and J.L.Dreyer (2004).
In vivo gene delivery of urokinase-type plasminogen activator with regulatable lentivirus induces behavioural changes in chronic cocaine administration.
  Eur J Neurosci, 20, 3473-3488.  
12539228 T.Nakamura, S.Mitsui, A.Okui, T.Miki, and N.Yamaguchi (2003).
Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate.
  Prostate, 54, 299-305.  
  11186232 B.A.Citron, I.V.Smirnova, P.M.Arnold, and B.W.Festoff (2000).
Upregulation of neurotoxic serine proteases, prothrombin, and protease-activated receptor 1 early after spinal cord injury.
  J Neurotrauma, 17, 1191-1203.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer